Pathogenic conversion of coagulase-negative staphylococci. 2017

Wenqi Yu, and Hwan Keun Kim, and Sabine Rauch, and Olaf Schneewind, and Dominique Missiakas
Department of Microbiology, University of Chicago, Chicago, IL, USA.

Humans and animals are colonized by members of the genus Staphylococcus, however only some of these species evolved to cause invasive disease. The genetic basis for conversion of commensal staphylococci into pathogens is not known. We hypothesized that Staphylococcus aureus genes for coagulation and agglutination in vertebrate blood (coa, vwb and clfA) may support pathogenic conversion. Expression of coa and vwb in Staphylococcus epidermidis or Staphylococcus simulans supported a coagulase-positive phenotype but not the ability to cause disease in a mouse model of bloodstream infection. However, the simultaneous expression of coa, vwb and clfA in coagulase-negative staphylococci enabled bacterial agglutination in plasma and enhanced survival of S. simulans in human whole blood. Agglutination of S. simulans in the bloodstream of infected mice upon expression of coa, vwb and clfA provided also a mean for dissemination and replication in distal organs. Thus, the acquisition of genes for bacterial agglutination with fibrin appear sufficient for the conversion of commensal staphylococci into invasive pathogens.

UI MeSH Term Description Entries
D008807 Mice, Inbred BALB C An inbred strain of mouse that is widely used in IMMUNOLOGY studies and cancer research. BALB C Mice, Inbred,BALB C Mouse, Inbred,Inbred BALB C Mice,Inbred BALB C Mouse,Mice, BALB C,Mouse, BALB C,Mouse, Inbred BALB C,BALB C Mice,BALB C Mouse
D003030 Coagulase Enzymes that cause coagulation in plasma by forming a complex with human PROTHROMBIN. Coagulases are produced by certain STAPHYLOCOCCUS and YERSINIA PESTIS. Staphylococci produce two types of coagulase: Staphylocoagulase, a free coagulase that produces true clotting of plasma, and Staphylococcal clumping factor, a bound coagulase in the cell wall that induces clumping of cells in the presence of fibrinogen. Staphylocoagulase,Staphylococcal Clumping Factor,Clumping Factor (Staphylococcal),Staphylococcus aureus clone pSCa2 of Coagulase,Staphylococcus aureus strain 213 of Coagulase,Staphylococcus aureus strain 8325-4 of Coagulase,Clumping Factor, Staphylococcal,Factor, Staphylococcal Clumping,Staphylococcus aureus strain 8325 4 of Coagulase
D004195 Disease Models, Animal Naturally-occurring or experimentally-induced animal diseases with pathological processes analogous to human diseases. Animal Disease Model,Animal Disease Models,Disease Model, Animal
D005260 Female Females
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D013210 Staphylococcus A genus of gram-positive, facultatively anaerobic, coccoid bacteria. Its organisms occur singly, in pairs, and in tetrads and characteristically divide in more than one plane to form irregular clusters. Natural populations of Staphylococcus are found on the skin and mucous membranes of warm-blooded animals. Some species are opportunistic pathogens of humans and animals.
D014774 Virulence The degree of pathogenicity within a group or species of microorganisms or viruses as indicated by case fatality rates and/or the ability of the organism to invade the tissues of the host. The pathogenic capacity of an organism is determined by its VIRULENCE FACTORS. Pathogenicity
D016470 Bacteremia The presence of viable bacteria circulating in the blood. Fever, chills, tachycardia, and tachypnea are common acute manifestations of bacteremia. The majority of cases are seen in already hospitalized patients, most of whom have underlying diseases or procedures which render their bloodstreams susceptible to invasion. Bacteremias
D037521 Virulence Factors Those components of an organism that determine its capacity to cause disease but are not required for its viability per se. Two classes have been characterized: TOXINS, BIOLOGICAL and surface adhesion molecules that effect the ability of the microorganism to invade and colonize a host. (From Davis et al., Microbiology, 4th ed. p486) Pathogenicity Factor,Pathogenicity Factors,Virulence Factor,Factor, Pathogenicity,Factor, Virulence,Factors, Pathogenicity,Factors, Virulence

Related Publications

Wenqi Yu, and Hwan Keun Kim, and Sabine Rauch, and Olaf Schneewind, and Dominique Missiakas
January 1987, Medycyna doswiadczalna i mikrobiologia,
Wenqi Yu, and Hwan Keun Kim, and Sabine Rauch, and Olaf Schneewind, and Dominique Missiakas
March 1993, Orvosi hetilap,
Wenqi Yu, and Hwan Keun Kim, and Sabine Rauch, and Olaf Schneewind, and Dominique Missiakas
January 1984, Medycyna doswiadczalna i mikrobiologia,
Wenqi Yu, and Hwan Keun Kim, and Sabine Rauch, and Olaf Schneewind, and Dominique Missiakas
October 1961, Nordisk medicin,
Wenqi Yu, and Hwan Keun Kim, and Sabine Rauch, and Olaf Schneewind, and Dominique Missiakas
May 1983, International journal of dermatology,
Wenqi Yu, and Hwan Keun Kim, and Sabine Rauch, and Olaf Schneewind, and Dominique Missiakas
August 2015, British journal of hospital medicine (London, England : 2005),
Wenqi Yu, and Hwan Keun Kim, and Sabine Rauch, and Olaf Schneewind, and Dominique Missiakas
April 1987, Zentralblatt fur Bakteriologie, Mikrobiologie, und Hygiene. Series A, Medical microbiology, infectious diseases, virology, parasitology,
Wenqi Yu, and Hwan Keun Kim, and Sabine Rauch, and Olaf Schneewind, and Dominique Missiakas
February 1981, Lancet (London, England),
Wenqi Yu, and Hwan Keun Kim, and Sabine Rauch, and Olaf Schneewind, and Dominique Missiakas
January 1981, Lancet (London, England),
Wenqi Yu, and Hwan Keun Kim, and Sabine Rauch, and Olaf Schneewind, and Dominique Missiakas
December 1986, Journal of medical microbiology,
Copied contents to your clipboard!